AbCellera Biologics (ABCL)
NASDAQ:ABCL
Holding ABCL?
Track your performance easily

AbCellera Biologics (ABCL) Financial Statements

1,541 Followers

AbCellera Biologics Financial Overview

AbCellera Biologics's market cap is currently ―. The company's EPS TTM is $-0.525; its P/E ratio is -5.19; AbCellera Biologics is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 7.32M$ 9.95M$ 12.36M$ 6.60M$ 10.06K
Gross Profit$ 7.32M$ 9.95M$ 12.36M$ 6.60M$ 10.06K
EBIT$ -48.19M$ -42.75M$ -48.60M$ -39.28M$ -38.00K
EBITDA$ -10.15M$ -35.98M$ -39.49M$ -31.87M$ -30.75K
Net Income Common Stockholders$ -36.93M$ -40.61M$ -47.15M$ -28.61M$ -30.53K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 670.36M$ 698.02M$ 760.59M$ 785.84M$ 795.69K
Total Assets$ 1.41B$ 1.46B$ 1.49B$ 1.51B$ 1.54M
Total Debt$ 79.46M$ 81.21M$ 84.49M$ 80.76M$ 84.03K
Net Debt$ -590.89M$ -616.81M$ -676.09M$ -705.08M$ -711.66K
Total Liabilities$ 301.51M$ 333.18M$ 335.78M$ 329.42M$ 342.34K
Stockholders Equity$ 1.11B$ 1.13B$ 1.15B$ 1.18B$ 1.19M
Cash Flow-
Free Cash Flow$ -50.08M$ -65.85M$ -34.04M$ -21.00M$ -7.30K
Operating Cash Flow$ -29.97M$ -41.71M$ -19.61M$ -106.00K$ 19.90K
Investing Cash Flow$ 52.10M$ 29.91M$ -24.32M$ -12.79M$ -34.39K
Financing Cash Flow$ 2.65M$ 2.83M$ 3.77M$ 6.63M$ 419.00
Currency in USD

AbCellera Biologics Earnings and Revenue History

AbCellera Biologics Debt to Assets

AbCellera Biologics Cash Flow

AbCellera Biologics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis